# Succinate Salt Version of GSK961081 for Healthy Volunteers

> **NCT00550225** · PHASE1 · COMPLETED · sponsor: **Theravance Biopharma** · enrollment: 18 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK961081
- **DRUG:** GSK961081 matching placebo

## Key facts

- **NCT ID:** NCT00550225
- **Lead sponsor:** Theravance Biopharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11-29
- **Primary completion:** 2008-01-08
- **Final completion:** 2008-01-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00550225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00550225, "Succinate Salt Version of GSK961081 for Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00550225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*